Syros earnings

Author: xtbs

August undefined, 2024

WebMar 2, 2024 · For the full year ended December 31, 2024, Syros reported a net loss of $94.7 million or $7.49 per share compared to a net loss of $86.6 million or $13.84 per share for the same period in 2024. WebMar 31, 2024 · These positive earnings estimate revisions suggest that analysts are becoming more optimistic on SYRS’ earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Syros Pharmaceuticals could be a solid choice for investors.

Syros Pharmaceuticals

WebApr 9, 2024 · Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. About the company Rewards Revenue is forecast to grow 58.79% per year Risk Analysis Shareholders have been substantially diluted in the past year WebMar 2, 2024 · Syros Pharmaceuticals, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $-0.75 million for the quarter ended December … the kingswood centre honeypot lane

Syros Pharmaceuticals, Inc. Common Stock (SYRS) …

WebIn depth view into Syros Pharmaceuticals Price including historical data from 2016, charts and stats. Syros Pharmaceuticals Inc (SYRS) ... Earnings Yield-467.1% Market Cap: 55.83M ... WebDec 31, 2024 · Syros Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports ... WebOn Invalid Date, Syros Pharmaceuticals (NASDAQ: SYRS) reported Q4 2024 earnings per share (EPS) of $4.44, up 217.46% year over year. Total Syros Pharmaceuticals earnings … the kingswood arms banstead

Syros Reports Second Quarter 2024 Financial Results and …

Syros Pharmaceuticals Earnings & Revenue 2013-2024: (NASDAQ: SYRS …

WebAug 5, 2024 · Syros recognized $3.2 million in revenue in the second quarter of 2024, including $2.5 million under its collaboration with GBT and $0.7 million under its collaboration with Incyte. Research and development expenses were $25.8 million for the first quarter of 2024, as compared to $14.8 million for the second quarter of 2024. WebEarnings Summary For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.28 per share, missing the Zacks Consensus Estimate of -$1.27 per share. This reflects a negative... the kingswood academyWebMar 15, 2024 · Syros recognized $5.7 million in revenue in the fourth quarter of 2024, consisting of $3.6 million in revenue recognized under its collaboration with GBT and $2.1 million recognized under its collaboration with Incyte, and $15.1 million for the year ended … Email Alerts - Syros Reports Fourth Quarter and Full Year 2024 Financial Results and ... Ernst & Young LLP 200 Clarendon Street Boston, MA 02116 T: 617-266-2000 the kingswood academy hull

"WebApr 12, 2024 · Syros Pharmaceuticals (NASDAQ:SYRS) has a market capitalization of $51.77 million and generates $14.88 million in revenue each year. The company earns $ … " - Syros earnings

Syros earnings

Syros Pharmaceuticals, Inc. (SYRS) Q4 2024 Earnings Call Transcript

WebApr 12, 2024 · Myelodysplastic Syndrome Epidemiology Insights. The total incident population of MDS in the 7MM was 41,850 in 2024, growing at a CAGR of 0.6% during the … WebApr 14, 2024 · Syros Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag: Mar 3: Q4 2024 Syros Pharmaceuticals Inc Earnings Call: Mar 2: Syros Pharmaceuticals, Inc. (SYRS) Q4 2024 Earnings Call Transcript: Mar 2: Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates: Mar 2: Syros …

Did you know?

WebAug 9, 2024 · Syros Pharmaceuticals, Inc. is estimated to report earnings on 11/04/2024. The upcoming earnings date is derived from an algorithm based on a company's … WebMar 22, 2024 · Syros Pharmaceuticals, Inc. (SYRS) latest earnings report: revenue, EPS, surprise, history, news and analysis. Syros Pharmaceuticals, Inc. (SYRS) Earnings Report …

WebAug 9, 2024 · Syros Pharmaceuticals, Inc. is estimated to report earnings on 11/04/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor,... WebNov 11, 2024 · Syros Pharmaceuticals (SYRS) is scheduled to announce Q3 earnings results on Monday, November 14th, before market open.The consensus EPS Estimate is -$3.83 and the consensus...

WebYou can buy and sell Syros (SYRS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... SYRS Earnings-$5.40-$3.60-$1.80. $0.00. Q3 FY21. Q4 FY21. Q1 FY22. Q2 FY22. WebSyros Pharmaceuticals said in a filing Monday that it expects its initial public offering of stock to price between $14 and $16 a share. The biopharmaceutical company, which has …

WebMar 24, 2024 · Syros Pharmaceuticals (SYRS) (Delayed Data from NSDQ) $2.74 USD -0.07 (-2.49%) Updated Mar 24, 2024 04:00 PM ET After-Market: $2.72 -0.02 (-0.73%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3...

WebMar 2, 2024 · Syros Pharmaceuticals (SYRS) Recent Earnings Syros Pharmaceuticals (SYRS) reported a Quarter December 2024 loss of $1.28 per share on revenue of $0.8 … the kingswoodWebSyros Pharmaceuticals's Earnings Outlook Mar. 1, 2024 at 1:01 p.m. ET on Benzinga.com Top 5 4th Quarter Trades of ADAGE CAPITAL PARTNERS GP, L.L.C. Feb. 17, 2024 at 10:00 p.m. ET on... the kingswood academy hull websiteWebMar 1, 2024 · Analysts estimate that Syros Pharmaceuticals will report an earnings per share (EPS) of $1.35. Syros Pharmaceuticals bulls will hope to hear the company … the kingswood and devoran hotel sidmouthWebOct 14, 2024 · PRESS RELEASE PR Newswire. Oct. 14, 2024, 08:00 AM. CAMBRIDGE, Mass., Oct. 14, 2024 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today expanded and ... the kingswood hubWebRepresents the company's profit divided by the outstanding shares of its common stock. -0.17. 95.53%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a … the kingswood companyWebAug 9, 2024 · Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q2 2024 Results - Earnings Call Transcript Aug. 09, 2024 2:29 PM ET Syros Pharmaceuticals, Inc. (SYRS) SA Transcripts 134.66K Follower... the kingswood centreWebApr 15, 2024 · Syros Pharmaceuticals Trading Down 2.5 %. Shares of Syros Pharmaceuticals stock opened at $2.70 on Friday. The firm has a market capitalization of $54.81 million, a price-to-earnings ratio of -0. ... the kingswood hotel sidmouth